SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard S. Schechter who wrote (356)11/15/1997 7:25:00 PM
From: Jim Mac  Read Replies (1) of 1754
 
The people at London Place Eye Centre (which was one of the pioneers of "no-touch" PRK) up in New Westminster, British Columbia, said their clinic in Hawaii has applied for an Investigational Device Exemption, allowing them to conduct U.S. trials, hopefully leading to approval within a few years.

LPEC's Don Johnson has worked closely with Visx to develop algorithms over the years, and now LPEC does only "no-touch" myopia treatments on the STAR, and "no-touch" hyperopia on Nidek since it has a larger treatment zone.

Don't expect U.S. approval too soon. Check out LPEC's homepage at lasereye.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News